Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)

NCT04327791 is registered in ClinicalTrials.gov with Bassett Healthcare as lead sponsor.

NCT NCT04327791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04327791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)
Lead sponsor
Bassett Healthcare
Phase
Phase 2/3
Overall status
Completed
Start date
April 3, 2020
Completion date
October 1, 2024
Enrollment
15 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

influenza